| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PIKFYVE PPP6C SND1 DCLRE1C CES1 AZGP1 MRPL44 AOAH PPM1G PPP1CA PPP1CB PPP1CC | 6.50e-07 | 807 | 51 | 12 | GO:0016788 |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 2.50e-06 | 85 | 51 | 5 | GO:0017018 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 8.50e-06 | 109 | 51 | 5 | GO:0004722 | |
| GeneOntologyMolecularFunction | phosphatase activity | 8.75e-05 | 287 | 51 | 6 | GO:0016791 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.19e-04 | 189 | 51 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 4.34e-04 | 386 | 51 | 6 | GO:0042578 | |
| GeneOntologyMolecularFunction | lamin binding | 1.06e-03 | 19 | 51 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.85e-03 | 231 | 51 | 4 | GO:0004518 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 4.04e-07 | 25 | 51 | 4 | GO:0043153 | |
| GeneOntologyBiologicalProcess | photoperiodism | 6.50e-07 | 28 | 51 | 4 | GO:0009648 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 8.66e-07 | 30 | 51 | 4 | GO:0009649 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 3.26e-05 | 248 | 51 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 3.54e-05 | 75 | 51 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 3.89e-05 | 256 | 51 | 6 | GO:0006470 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 2.07e-04 | 347 | 51 | 6 | GO:0016311 | |
| GeneOntologyBiologicalProcess | rhythmic process | 2.52e-04 | 360 | 51 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 3.46e-04 | 135 | 51 | 4 | GO:0042752 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 5.05e-07 | 7 | 52 | 3 | GO:0072357 | |
| GeneOntologyCellularComponent | protein phosphatase type 1 complex | 1.37e-05 | 19 | 52 | 3 | GO:0000164 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 1.25e-04 | 39 | 52 | 3 | GO:0031463 | |
| GeneOntologyCellularComponent | glycogen granule | 1.68e-04 | 8 | 52 | 2 | GO:0042587 | |
| GeneOntologyCellularComponent | phosphatase complex | 3.48e-04 | 55 | 52 | 3 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 3.48e-04 | 55 | 52 | 3 | GO:0008287 | |
| MousePheno | abnormal DNA replication | 8.42e-05 | 28 | 43 | 3 | MP:0008057 | |
| MousePheno | fatigue | 9.38e-05 | 78 | 43 | 4 | MP:0002899 | |
| Domain | STPPase_N | 2.04e-08 | 3 | 52 | 3 | IPR031675 | |
| Domain | STPPase_N | 2.04e-08 | 3 | 52 | 3 | PF16891 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 3.75e-08 | 13 | 52 | 4 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 3.75e-08 | 13 | 52 | 4 | PS00125 | |
| Domain | PP2Ac | 3.75e-08 | 13 | 52 | 4 | SM00156 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.04e-06 | 28 | 52 | 4 | IPR004843 | |
| Domain | Metallophos | 1.04e-06 | 28 | 52 | 4 | PF00149 | |
| Domain | Metallo-depent_PP-like | 1.39e-06 | 30 | 52 | 4 | IPR029052 | |
| Domain | - | 1.39e-06 | 30 | 52 | 4 | 3.60.21.10 | |
| Domain | MATH/TRAF_dom | 4.93e-04 | 12 | 52 | 2 | IPR002083 | |
| Domain | MATH | 4.93e-04 | 12 | 52 | 2 | PS50144 | |
| Domain | MATH | 4.93e-04 | 12 | 52 | 2 | SM00061 | |
| Domain | MATH | 4.93e-04 | 12 | 52 | 2 | PF00917 | |
| Domain | - | 6.77e-04 | 14 | 52 | 2 | 2.60.210.10 | |
| Domain | BTB | 1.02e-03 | 160 | 52 | 4 | PS50097 | |
| Domain | BTB | 1.57e-03 | 180 | 52 | 4 | SM00225 | |
| Domain | BTB/POZ_dom | 1.74e-03 | 185 | 52 | 4 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.88e-03 | 189 | 52 | 4 | IPR011333 | |
| Domain | TRAF-like | 2.02e-03 | 24 | 52 | 2 | IPR008974 | |
| Domain | BTB | 5.80e-03 | 131 | 52 | 3 | PF00651 | |
| Domain | AAA+_ATPase | 7.53e-03 | 144 | 52 | 3 | IPR003593 | |
| Domain | AAA | 7.53e-03 | 144 | 52 | 3 | SM00382 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 1.17e-06 | 8 | 40 | 3 | M47933 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 4.57e-06 | 12 | 40 | 3 | M47887 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE | 4.57e-06 | 12 | 40 | 3 | M47891 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 1.16e-05 | 16 | 40 | 3 | M48235 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 4.11e-05 | 24 | 40 | 3 | M10064 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 5.26e-05 | 26 | 40 | 3 | M628 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 1.67e-04 | 38 | 40 | 3 | M27856 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 2.09e-04 | 41 | 40 | 3 | M39655 | |
| Pathway | REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS | 2.17e-04 | 8 | 40 | 2 | M38999 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 2.46e-04 | 201 | 40 | 5 | M39605 | |
| Pathway | WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION | 2.95e-04 | 46 | 40 | 3 | M39901 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.15e-04 | 47 | 40 | 3 | M646 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.72e-04 | 121 | 40 | 4 | M39823 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.02e-03 | 70 | 40 | 3 | M3115 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.02e-03 | 70 | 40 | 3 | M938 | |
| Pathway | REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE | 1.44e-03 | 20 | 40 | 2 | MM14673 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.60e-03 | 82 | 40 | 3 | M27626 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.84e-03 | 314 | 40 | 5 | M39428 | |
| Pathway | REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE | 1.91e-03 | 23 | 40 | 2 | M27023 | |
| Pubmed | 3.15e-09 | 3 | 52 | 3 | 7857673 | ||
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 3.15e-09 | 3 | 52 | 3 | 25073485 | |
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 3.15e-09 | 3 | 52 | 3 | 21712997 | |
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 1.26e-08 | 4 | 52 | 3 | 16131488 | |
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 10194355 | ||
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 1.26e-08 | 4 | 52 | 3 | 23277204 | |
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 22768081 | ||
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 12226088 | ||
| Pubmed | N-CoR controls differentiation of neural stem cells into astrocytes. | 1.26e-08 | 4 | 52 | 3 | 12410313 | |
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 1.26e-08 | 4 | 52 | 3 | 12788939 | |
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 20424263 | ||
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 23197154 | ||
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 12016208 | ||
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 11551964 | ||
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 28615442 | ||
| Pubmed | Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. | 3.15e-08 | 5 | 52 | 3 | 10209101 | |
| Pubmed | The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. | 3.15e-08 | 5 | 52 | 3 | 17511879 | |
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 25487150 | ||
| Pubmed | 6.28e-08 | 6 | 52 | 3 | 25785436 | ||
| Pubmed | 6.28e-08 | 6 | 52 | 3 | 21998301 | ||
| Pubmed | Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. | 6.28e-08 | 6 | 52 | 3 | 18641122 | |
| Pubmed | SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1. | 6.28e-08 | 6 | 52 | 3 | 14640981 | |
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 1.10e-07 | 7 | 52 | 3 | 18689497 | |
| Pubmed | SARP, a new alternatively spliced protein phosphatase 1 and DNA interacting protein. | 1.10e-07 | 7 | 52 | 3 | 17123353 | |
| Pubmed | 1.10e-07 | 7 | 52 | 3 | 12147701 | ||
| Pubmed | 1.76e-07 | 8 | 52 | 3 | 12036313 | ||
| Pubmed | 1.76e-07 | 8 | 52 | 3 | 16262633 | ||
| Pubmed | 1.76e-07 | 8 | 52 | 3 | 21930935 | ||
| Pubmed | RRP1B targets PP1 to mammalian cell nucleoli and is associated with Pre-60S ribosomal subunits. | 2.63e-07 | 9 | 52 | 3 | 20926688 | |
| Pubmed | 2.63e-07 | 9 | 52 | 3 | 21566083 | ||
| Pubmed | 6.87e-07 | 12 | 52 | 3 | 10830164 | ||
| Pubmed | 1.13e-06 | 14 | 52 | 3 | 16048649 | ||
| Pubmed | PAXBP1 PPP6C SND1 DYNC2H1 SYNE1 EPHA2 MRPL44 SLC30A1 NCDN PPM1G PPP6R3 PPP1CC | 1.50e-06 | 1487 | 52 | 12 | 33957083 | |
| Pubmed | 1.78e-06 | 58 | 52 | 4 | 31067491 | ||
| Pubmed | 2.11e-06 | 17 | 52 | 3 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 2.11e-06 | 17 | 52 | 3 | 21351466 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 16740475 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 2544298 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20399258 | ||
| Pubmed | Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity. | 2.19e-06 | 2 | 52 | 2 | 27469204 | |
| Pubmed | Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity. | 2.19e-06 | 2 | 52 | 2 | 20592054 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9882500 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 2.19e-06 | 2 | 52 | 2 | 23176181 | |
| Pubmed | Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. | 2.19e-06 | 2 | 52 | 2 | 16651542 | |
| Pubmed | 3.11e-06 | 606 | 52 | 8 | 36538041 | ||
| Pubmed | 5.47e-06 | 23 | 52 | 3 | 21360054 | ||
| Pubmed | 5.72e-06 | 300 | 52 | 6 | 28561026 | ||
| Pubmed | 6.24e-06 | 24 | 52 | 3 | 27754788 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 12138106 | ||
| Pubmed | The PP1 binding code: a molecular-lego strategy that governs specificity. | 6.57e-06 | 3 | 52 | 2 | 22360570 | |
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 6.57e-06 | 3 | 52 | 2 | 11739654 | |
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 6.57e-06 | 3 | 52 | 2 | 19074462 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 11588169 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 28296156 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 17965019 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 9882488 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 7.41e-06 | 910 | 52 | 9 | 36736316 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23116618 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 26147384 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23499489 | ||
| Pubmed | PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation. | 1.31e-05 | 4 | 52 | 2 | 22299668 | |
| Pubmed | Structural basis for protein phosphatase 1 regulation and specificity. | 1.31e-05 | 4 | 52 | 2 | 22284538 | |
| Pubmed | Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up. | 1.31e-05 | 4 | 52 | 2 | 15475734 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21471512 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 10880350 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 12016225 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 12221103 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 15226296 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 19621075 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 17202132 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 10807923 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 12036952 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 26334248 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 24902662 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 1.38e-05 | 31 | 52 | 3 | 20516061 | |
| Pubmed | A quantitative telomeric chromatin isolation protocol identifies different telomeric states. | 1.83e-05 | 34 | 52 | 3 | 24270157 | |
| Pubmed | 2.02e-05 | 221 | 52 | 5 | 31796584 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 10773462 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 12624094 | ||
| Pubmed | HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. | 2.19e-05 | 5 | 52 | 2 | 9009195 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 19581931 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 22801782 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 15016827 | ||
| Pubmed | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. | 2.19e-05 | 5 | 52 | 2 | 22632832 | |
| Pubmed | The nuclear envelope protein, LAP1B, is a novel protein phosphatase 1 substrate. | 2.19e-05 | 5 | 52 | 2 | 24116158 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 2.24e-05 | 573 | 52 | 7 | 28330616 | |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 2.56e-05 | 38 | 52 | 3 | 30629181 | |
| Pubmed | 2.96e-05 | 1084 | 52 | 9 | 11544199 | ||
| Pubmed | 3.00e-05 | 40 | 52 | 3 | 23555304 | ||
| Pubmed | 3.11e-05 | 119 | 52 | 4 | 23508102 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.16e-05 | 605 | 52 | 7 | 28977666 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 20065038 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 20186153 | ||
| Pubmed | Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. | 3.28e-05 | 6 | 52 | 2 | 23088536 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 3.43e-05 | 247 | 52 | 5 | 32989298 | |
| Pubmed | 3.71e-05 | 251 | 52 | 5 | 27507650 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PAXBP1 SND1 GPN1 SLC30A1 NCDN XAB2 PPM1G PPP6R3 PPP1CA PPP1CB | 4.00e-05 | 1415 | 52 | 10 | 28515276 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.22e-05 | 258 | 52 | 5 | 37794589 | |
| Pubmed | 4.25e-05 | 634 | 52 | 7 | 34591612 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 17369396 | ||
| Interaction | PPP1R2C interactions | 6.47e-08 | 4 | 52 | 3 | int:PPP1R2C | |
| Interaction | CSRNP2 interactions | 1.61e-07 | 5 | 52 | 3 | int:CSRNP2 | |
| Interaction | SFRP5 interactions | 3.22e-07 | 6 | 52 | 3 | int:SFRP5 | |
| Interaction | RASSF9 interactions | 3.03e-06 | 39 | 52 | 4 | int:RASSF9 | |
| Interaction | PPP1R2B interactions | 5.78e-06 | 14 | 52 | 3 | int:PPP1R2B | |
| Interaction | RYR2 interactions | 1.51e-05 | 58 | 52 | 4 | int:RYR2 | |
| Interaction | PPP1R3B interactions | 1.52e-05 | 19 | 52 | 3 | int:PPP1R3B | |
| Interaction | PLCL2 interactions | 1.52e-05 | 19 | 52 | 3 | int:PLCL2 | |
| Interaction | CSRNP1 interactions | 2.09e-05 | 21 | 52 | 3 | int:CSRNP1 | |
| Interaction | NUP50 interactions | 2.60e-05 | 341 | 52 | 7 | int:NUP50 | |
| Interaction | SFRP1 interactions | 3.58e-05 | 25 | 52 | 3 | int:SFRP1 | |
| Interaction | PPP1R2 interactions | 3.97e-05 | 74 | 52 | 4 | int:PPP1R2 | |
| Interaction | UBXN2A interactions | 4.04e-05 | 26 | 52 | 3 | int:UBXN2A | |
| Interaction | PDE6B interactions | 5.65e-05 | 29 | 52 | 3 | int:PDE6B | |
| Interaction | LRRC1 interactions | 6.23e-05 | 83 | 52 | 4 | int:LRRC1 | |
| Interaction | AURKA interactions | 6.46e-05 | 696 | 52 | 9 | int:AURKA | |
| Interaction | PPP1R11 interactions | 6.92e-05 | 31 | 52 | 3 | int:PPP1R11 | |
| Interaction | PPP2R5C interactions | 7.49e-05 | 87 | 52 | 4 | int:PPP2R5C | |
| Interaction | PPP1R3C interactions | 8.37e-05 | 33 | 52 | 3 | int:PPP1R3C | |
| Interaction | DELEC1 interactions | 9.16e-05 | 34 | 52 | 3 | int:DELEC1 | |
| Interaction | DLGAP1 interactions | 9.95e-05 | 180 | 52 | 5 | int:DLGAP1 | |
| Interaction | SFRP2 interactions | 1.00e-04 | 35 | 52 | 3 | int:SFRP2 | |
| Interaction | PHACTR3 interactions | 1.18e-04 | 37 | 52 | 3 | int:PHACTR3 | |
| Interaction | CLOCK interactions | 1.39e-04 | 102 | 52 | 4 | int:CLOCK | |
| Interaction | PPP1R15A interactions | 1.50e-04 | 40 | 52 | 3 | int:PPP1R15A | |
| Interaction | AKAP11 interactions | 1.50e-04 | 104 | 52 | 4 | int:AKAP11 | |
| Interaction | PQBP1 interactions | 1.55e-04 | 105 | 52 | 4 | int:PQBP1 | |
| Interaction | MDM4 interactions | 1.55e-04 | 105 | 52 | 4 | int:MDM4 | |
| Interaction | PPP1R37 interactions | 1.61e-04 | 41 | 52 | 3 | int:PPP1R37 | |
| Interaction | ZFYVE9 interactions | 1.61e-04 | 106 | 52 | 4 | int:ZFYVE9 | |
| Interaction | RASSF7 interactions | 1.73e-04 | 42 | 52 | 3 | int:RASSF7 | |
| Interaction | TPX2 interactions | 1.79e-04 | 204 | 52 | 5 | int:TPX2 | |
| Interaction | CLEC16A interactions | 1.93e-04 | 629 | 52 | 8 | int:CLEC16A | |
| Interaction | UBXN2B interactions | 2.13e-04 | 45 | 52 | 3 | int:UBXN2B | |
| Interaction | RORC interactions | 2.13e-04 | 45 | 52 | 3 | int:RORC | |
| Interaction | ADISSP interactions | 2.27e-04 | 46 | 52 | 3 | int:ADISSP | |
| Interaction | ANKRD44 interactions | 2.58e-04 | 48 | 52 | 3 | int:ANKRD44 | |
| Interaction | TPRN interactions | 2.75e-04 | 49 | 52 | 3 | int:TPRN | |
| Interaction | UXT interactions | 3.22e-04 | 127 | 52 | 4 | int:UXT | |
| Interaction | TRIOBP interactions | 3.22e-04 | 127 | 52 | 4 | int:TRIOBP | |
| Interaction | KIF18A interactions | 3.28e-04 | 52 | 52 | 3 | int:KIF18A | |
| Interaction | PPP1R9A interactions | 3.32e-04 | 128 | 52 | 4 | int:PPP1R9A | |
| Interaction | PPP1R27 interactions | 3.54e-04 | 11 | 52 | 2 | int:PPP1R27 | |
| Interaction | DNAJC17 interactions | 3.95e-04 | 134 | 52 | 4 | int:DNAJC17 | |
| Interaction | NMRAL1 interactions | 4.08e-04 | 244 | 52 | 5 | int:NMRAL1 | |
| Interaction | UACA interactions | 4.18e-04 | 136 | 52 | 4 | int:UACA | |
| Interaction | PPP1R1B interactions | 4.24e-04 | 12 | 52 | 2 | int:PPP1R1B | |
| Interaction | PACS1 interactions | 4.30e-04 | 57 | 52 | 3 | int:PACS1 | |
| Interaction | PPP1R16A interactions | 4.30e-04 | 57 | 52 | 3 | int:PPP1R16A | |
| Interaction | PPP1R12C interactions | 4.52e-04 | 58 | 52 | 3 | int:PPP1R12C | |
| Interaction | PPP1R18 interactions | 4.79e-04 | 141 | 52 | 4 | int:PPP1R18 | |
| Interaction | MAP4K4 interactions | 4.90e-04 | 254 | 52 | 5 | int:MAP4K4 | |
| Interaction | LINC02870 interactions | 5.00e-04 | 13 | 52 | 2 | int:LINC02870 | |
| Interaction | URI1 interactions | 5.05e-04 | 143 | 52 | 4 | int:URI1 | |
| Interaction | KIAA1143 interactions | 5.25e-04 | 61 | 52 | 3 | int:KIAA1143 | |
| Interaction | RPRD2 interactions | 5.46e-04 | 146 | 52 | 4 | int:RPRD2 | |
| Interaction | SCRIB interactions | 6.04e-04 | 266 | 52 | 5 | int:SCRIB | |
| Interaction | PPP1R3A interactions | 6.32e-04 | 65 | 52 | 3 | int:PPP1R3A | |
| Interaction | PTPN7 interactions | 6.32e-04 | 65 | 52 | 3 | int:PTPN7 | |
| Interaction | PPP1R16B interactions | 6.32e-04 | 65 | 52 | 3 | int:PPP1R16B | |
| Interaction | STAM interactions | 6.51e-04 | 153 | 52 | 4 | int:STAM | |
| Interaction | RUVBL1 interactions | 6.52e-04 | 575 | 52 | 7 | int:RUVBL1 | |
| Interaction | POU5F1 interactions | 7.15e-04 | 584 | 52 | 7 | int:POU5F1 | |
| Interaction | PPP1R12B interactions | 7.21e-04 | 68 | 52 | 3 | int:PPP1R12B | |
| Interaction | MYO16 interactions | 7.66e-04 | 16 | 52 | 2 | int:MYO16 | |
| Interaction | PRR16 interactions | 7.66e-04 | 16 | 52 | 2 | int:PRR16 | |
| Interaction | WBP11 interactions | 7.70e-04 | 160 | 52 | 4 | int:WBP11 | |
| Interaction | NLRP7 interactions | 7.88e-04 | 161 | 52 | 4 | int:NLRP7 | |
| Interaction | INF2 interactions | 8.64e-04 | 288 | 52 | 5 | int:INF2 | |
| Interaction | PPP6R1 interactions | 8.83e-04 | 166 | 52 | 4 | int:PPP6R1 | |
| Interaction | CDCA2 interactions | 8.87e-04 | 73 | 52 | 3 | int:CDCA2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 2.56e-05 | 149 | 52 | 4 | chr2p23 | |
| Cytoband | 2p23.3 | 2.73e-03 | 68 | 52 | 2 | 2p23.3 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 8.31e-09 | 13 | 35 | 4 | 693 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.19e-03 | 134 | 35 | 3 | 861 | |
| GeneFamily | Sterile alpha motif domain containing | 1.26e-02 | 88 | 35 | 2 | 760 | |
| Coexpression | MOOTHA_GLYCOGEN_METABOLISM | 9.55e-06 | 21 | 52 | 3 | M10376 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | 2.32e-05 | 435 | 52 | 7 | M41115 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 4.45e-05 | 197 | 52 | 5 | M5475 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN | 4.56e-05 | 198 | 52 | 5 | M5324 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 4.67e-05 | 199 | 52 | 5 | M7341 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-08 | 178 | 52 | 6 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-06 | 187 | 52 | 5 | 8c69fd469df2915c56ede534cee3ef23d5f64ebf | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 3.20e-06 | 195 | 52 | 5 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.28e-06 | 196 | 52 | 5 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.36e-06 | 197 | 52 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 154 | 52 | 4 | 6c1e7682c43c40b58b371c58deb10b839700ebcc | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 4.02e-05 | 164 | 52 | 4 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.29e-05 | 176 | 52 | 4 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 176 | 52 | 4 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.03e-05 | 182 | 52 | 4 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.16e-05 | 183 | 52 | 4 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.69e-05 | 187 | 52 | 4 | 7375f70a970a5d5a58b7c33ada2dcf6dcef525c6 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.98e-05 | 189 | 52 | 4 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.12e-05 | 190 | 52 | 4 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 7.41e-05 | 192 | 52 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.41e-05 | 192 | 52 | 4 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.41e-05 | 192 | 52 | 4 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.56e-05 | 193 | 52 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-05 | 194 | 52 | 4 | a8dc3336aa4ef497f6d26cede02ddac425e7c655 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.72e-05 | 194 | 52 | 4 | ecdfc27d06e363fb23f0309f26ef6404a89f14ec | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.87e-05 | 195 | 52 | 4 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_CTLs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.87e-05 | 195 | 52 | 4 | 7df67ad5c62235474ee56ea07a957253d45f066b | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 7.87e-05 | 195 | 52 | 4 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.87e-05 | 195 | 52 | 4 | 3af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d | |
| ToppCell | MS-CD4-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 8.03e-05 | 196 | 52 | 4 | d0217eccaa2cbf4ce9934e9d2e0c34a7f5c1a57e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 197 | 52 | 4 | 1ca06d6d288cb58a6e8062ebc01831e58ee5be4b | |
| ToppCell | Mild/Remission-B_intermediate-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.19e-05 | 197 | 52 | 4 | 5370dda4a25e3a53d6fe2c887b7dabd7a58462b4 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.19e-05 | 197 | 52 | 4 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | T/NK_cells-NKT_cell|T/NK_cells / Lineage and Cell class | 8.19e-05 | 197 | 52 | 4 | 10702e61b510bfc7f54047ab3d8c700451a662b2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.51e-05 | 199 | 52 | 4 | fd3706f256e33cf348774bea0ba0df6d41fd96e3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.51e-05 | 199 | 52 | 4 | 252f0084fa17770f4c34e21066519d7f7cad75d9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.51e-05 | 199 | 52 | 4 | e981b159841222a6838effff1059c683c20ecf5b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.51e-05 | 199 | 52 | 4 | 8cdd5aa30a8112b77f5d02b40c45b63f541e1476 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-NK|COVID-19_Convalescent / Disease group, lineage and cell class | 8.51e-05 | 199 | 52 | 4 | 9809d996a2c3f5384707646a3929e1d6b85dcdc2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.51e-05 | 199 | 52 | 4 | a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc | |
| ToppCell | remission-NK|remission / disease stage, cell group and cell class | 8.51e-05 | 199 | 52 | 4 | 31ed2a314e8f70980ea0686242446d66929288e9 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T|Leuk-UTI / Disease, condition lineage and cell class | 8.51e-05 | 199 | 52 | 4 | b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.51e-05 | 199 | 52 | 4 | 899642ff6bb6c1612f14a9a049b4344ae694752a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.51e-05 | 199 | 52 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | remission-CD8+_Tem|World / disease stage, cell group and cell class | 8.68e-05 | 200 | 52 | 4 | 0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.68e-05 | 200 | 52 | 4 | 2bd8c35484fe6b0bc0f9314216786baaa97d1e95 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-NK|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.68e-05 | 200 | 52 | 4 | 50d844683dcfe35e59fffa0c23f1532d692d0c17 | |
| ToppCell | COVID-19_Convalescent-NK|COVID-19_Convalescent / Disease condition and Cell class | 8.68e-05 | 200 | 52 | 4 | dd62477b12c54065d4b70866c1523e9c217a48a9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.73e-04 | 108 | 52 | 3 | 63d45cc3ee149a7baf255b70409f8ea54c56157b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.73e-04 | 108 | 52 | 3 | d57eeda825b6e0e64bae185896ae7eea6a2a50e9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.73e-04 | 108 | 52 | 3 | c2aa6bf8554bfb6b0f9c5f6658601c6cf7c8bdbc | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.73e-04 | 108 | 52 | 3 | db8472616886c6195f8c27c00f00133a9c10691d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.19e-04 | 125 | 52 | 3 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.13e-04 | 134 | 52 | 3 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 5.24e-04 | 135 | 52 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.24e-04 | 135 | 52 | 3 | e908aacb72a8c340f06cf5b4a6b70c2faac4d027 | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.85e-04 | 148 | 52 | 3 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.54e-04 | 153 | 52 | 3 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.69e-04 | 154 | 52 | 3 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.43e-04 | 159 | 52 | 3 | 57df5c9b678a15eb5e025e1a80de2e6769cc13d5 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.58e-04 | 160 | 52 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.58e-04 | 160 | 52 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | Control-APC-like-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 8.58e-04 | 160 | 52 | 3 | 463dd624ca5c375b6ff7c269f4ef4b9d74f4b669 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.74e-04 | 161 | 52 | 3 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-04 | 163 | 52 | 3 | bb09e6ca3406eee0593d9a312db7e05934309dd2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.38e-04 | 165 | 52 | 3 | e460e03992781073cd836a655f15dda3157cea55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-04 | 166 | 52 | 3 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 9.71e-04 | 167 | 52 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.88e-04 | 168 | 52 | 3 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.88e-04 | 168 | 52 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 169 | 52 | 3 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-03 | 169 | 52 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 169 | 52 | 3 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-03 | 170 | 52 | 3 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-03 | 170 | 52 | 3 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.02e-03 | 170 | 52 | 3 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-03 | 171 | 52 | 3 | d6d8ea45b443d95f64720c9bc07d324148f5b239 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 171 | 52 | 3 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 171 | 52 | 3 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 172 | 52 | 3 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 172 | 52 | 3 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-03 | 172 | 52 | 3 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-03 | 172 | 52 | 3 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-03 | 172 | 52 | 3 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-03 | 172 | 52 | 3 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-03 | 172 | 52 | 3 | e3a8891694343b6b01e80a200ae338d24797e417 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 173 | 52 | 3 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 173 | 52 | 3 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-03 | 173 | 52 | 3 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-03 | 174 | 52 | 3 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-03 | 174 | 52 | 3 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-03 | 175 | 52 | 3 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-03 | 175 | 52 | 3 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-03 | 175 | 52 | 3 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-03 | 175 | 52 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | BAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters | 1.11e-03 | 175 | 52 | 3 | daf014e15a354956e9149c83fd89d0af0d07eb00 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-03 | 175 | 52 | 3 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-03 | 175 | 52 | 3 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| Disease | cerebellar ataxia (is_implicated_in) | 2.58e-05 | 5 | 48 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 1.25e-04 | 157 | 48 | 4 | DOID:9256 (is_marker_for) | |
| Disease | metabolite measurement | 2.84e-04 | 560 | 48 | 6 | EFO_0004725 | |
| Disease | LEOPARD Syndrome | 5.86e-04 | 22 | 48 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 6.99e-04 | 24 | 48 | 2 | C0028326 | |
| Disease | colorectal cancer (is_implicated_in) | 1.02e-03 | 121 | 48 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.41e-03 | 34 | 48 | 2 | EFO_0009926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLYLNIYTPADLTKK | 116 | P23141 | |
| TTGKILEKIYLAPYC | 136 | Q5H9S7 | |
| EIPLKDLKYYRCILL | 221 | Q9H981 | |
| VLVLLYLYLTPCPCK | 411 | Q86SJ2 | |
| PCLLEKAYAKLLGSY | 166 | Q6MZZ7 | |
| ICKYPLQLAELLKYT | 246 | O43307 | |
| SYLPEKLFLKTTCYL | 71 | P28039 | |
| KLKYTEAYPCLLSVL | 366 | Q86T65 | |
| TSCLFLKLLGSKLFY | 151 | Q4G0X4 | |
| LIKEGAPSLLCKYFL | 481 | Q9UBB6 | |
| FRGDYLLLKPEKCYL | 281 | Q9H9P8 | |
| YLKSYNIPALKRKCI | 546 | P56645 | |
| TSYKDAYIGLCLPKL | 611 | Q9Y5B6 | |
| LIKELPDTHYCLLKY | 156 | O94988 | |
| LYACSILYKTKLPFI | 171 | Q9HCN4 | |
| LKQLVLKCPALLYYS | 281 | Q49AM1 | |
| LKCPALLYYSVPVLE | 286 | Q49AM1 | |
| ILCFLPSYKLLEKLK | 691 | Q9BX63 | |
| LETICLLLAYKIKYP | 101 | P62136 | |
| ETICLLLAYKIKYPE | 101 | P62140 | |
| LRSILLLYATYKKCT | 156 | Q96PS1 | |
| NPKILLLKCSIEYLY | 701 | Q9Y2I7 | |
| KLVYTPLTDKCYLTL | 1661 | Q8NCM8 | |
| KVYLYCSPVTKELLL | 56 | Q96SD1 | |
| PCLPYTSKLVKTLLY | 206 | Q7RTS9 | |
| LLSVRVYYKKCPELL | 191 | P29317 | |
| FTSLYNLLKTKLCPY | 266 | Q9NYP3 | |
| ILYKYDCSLLDPLPK | 431 | Q9NYL5 | |
| DLKKRYCYLPELLQT | 221 | O14682 | |
| LLPYIKKVAIYLCRN | 1471 | Q5TBA9 | |
| LLPLYSKRYILFCLV | 196 | O95977 | |
| ALPLYFVGLYCDKKL | 266 | Q9H9J2 | |
| EPYLLFSTDKKLLLC | 161 | Q6ZRF8 | |
| LYERALKLLPCSYKL | 56 | Q9HCS7 | |
| LTKVKECYSPLLYES | 796 | Q8NF91 | |
| EVALYCAKYLPDIIK | 66 | O15355 | |
| KLYLPKETCLITFLL | 541 | Q7KZF4 | |
| SRSKLYEYLDIKCVP | 306 | Q6UW49 | |
| CSSTKLLKFYELPAL | 856 | Q63HN8 | |
| REYLKNLPLLSKYCG | 191 | P17752 | |
| LDKYVEIARLCKYLP | 6 | O00743 | |
| LGPALKLCYYIEKLK | 681 | Q9UQR0 | |
| KDYLSLYLLLVSCPK | 81 | Q6IQ16 | |
| KDYLSLYLLLVSCPK | 81 | O43791 | |
| YSSLNKVILYCLSKP | 2011 | Q6ZS81 | |
| LETICLLLAYKIKYP | 101 | P36873 | |
| YLEEECPATLRKYLK | 181 | P25311 | |
| KPYECKLYGKALSRL | 241 | Q8N8L2 | |
| CILLYTTYPLLKESA | 326 | Q9Y6M5 | |
| LKTILSYLYVCPTNK | 226 | Q8WY21 | |
| EKIRYKYPNISCELL | 71 | Q5H9R7 | |
| CTPLLYQLVYKLTKE | 456 | Q9Y3Q0 | |
| YELSCYLPQEKDLKI | 1606 | Q9NZM1 |